-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R8OlrErS8IJ+oBbyzkb/MUzfExdFp/euuey1xWYeu1WFsTU4JU9Rbunp3hybayD+
 ggr38vRV7EXv+NFVuAAhzg==

<SEC-DOCUMENT>0001104659-07-016141.txt : 20070305
<SEC-HEADER>0001104659-07-016141.hdr.sgml : 20070305
<ACCEPTANCE-DATETIME>20070305090727
ACCESSION NUMBER:		0001104659-07-016141
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20070305
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070305
DATE AS OF CHANGE:		20070305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		07669701

	BUSINESS ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a07-7113_18k.htm
<DESCRIPTION>8-K
<TEXT>
<html>

<head>







</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-weight:bold;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;">UNITED
STATES</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;">SECURITIES
AND EXCHANGE COMMISSION</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Washington,
D.C. 20549</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;">FORM 8-K</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;">CURRENT REPORT</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of
earliest event reported): March 5, 2007</font></p>

<p style="font-weight:bold;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International, Inc.</font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant
as specified in its charter)</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="31%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.74%;">
  <p align="center" style="font-size:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><!-- SET mrlNoTableShading --><b>Delaware</b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.74%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-13463</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.74%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="31%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.74%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other
  jurisdiction of incorporation)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.74%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File
  Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:2.38%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:31.74%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer
  Identification No.)</font></p>
  </td>
 </tr>
</table>

<p style="line-height:normal;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="font-weight:bold;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">3349 Highway 138,
Building D, Suite B</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Wall, NJ 07719</font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal
executive offices)</font></p>

<p style="font-weight:bold;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">(732)&nbsp;359-1100</font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone
number, including area code)</font></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (<i>see</i> General
Instruction A.2 below):</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))</p>

<p style="font-size:10.0pt;margin:0pt 0pt 12.0pt 36.0pt;text-indent:-36.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-commencement
communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR
240.13e-4(c))</p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\6115926147_P83101_1803400\7113-1-ba.htm',USER='jmsproofassembler',CD='Mar  2 15:09 2007' -->



<br clear="all" style="page-break-before:always;">
<div>


<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.02.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Results of
Operations and Financial Condition.</font></b><a name="Item2_02_ResultsOfOperationsAndFi_155709"></a></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
March 5, 2007, BIO-key International, Inc. (the &#147;Company&#148;) issued a press
release announcing its financial results for its fourth quarter and year ended
December 31, 2006. &nbsp;A copy of such press release of the Registrant is
attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference in its entirety.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The information, including the exhibit attached hereto, in this Current Report
on Form 8-K shall not be deemed &#147;filed&#148; for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise
subject to the liabilities of that Section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as otherwise expressly stated in such filing.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Financial
Statements, Pro Forma Financial Information and Exhibits.</font></b><a name="Item9_01_FinancialStatementsProFo_155710"></a></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Press Release, dated March 5, 2007,
issued by the Company.</font></p>


 <p style="margin:24.0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='2',FILE='C:\fc\61145731646_P83101_1803400\7113-1-ca.htm',USER='jmsproofassembler',CD='Mar  2 14:57 2007' -->



<br clear="all" style="page-break-before:always;">
<div>


<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">SIGNATURES<a name="Signatures_160120"></a></font></b></p>

<p style="margin:6.0pt 0pt 12.0pt;text-indent:36.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading --></p>
  </td>
  <td width="49%" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:49.4%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-KEY INTERNATIONAL, INC.</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="44%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:44.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: March 5, 2007</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="44%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:44.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="44%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:44.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:44.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Francis J. Cusick</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="44%" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:44.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Francis J. Cusick</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="50%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:50.6%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:4.96%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="44%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:44.44%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>


 <p style="margin:24.0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='3',FILE='C:\fc\61152911874_D11089_1803610\7113-1-ja.htm',USER='jmsproofassembler',CD='Mar  2 15:29 2007' -->
<br clear="all" style="page-break-before:always;">

<p style="color:black;margin:0pt 0pt 12.0pt 274.5pt;text-align:center;text-indent:-274.5pt;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p><p style="color:black;margin:0pt 0pt 12.0pt 274.5pt;text-align:center;text-indent:-274.5pt;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-weight:bold;">EXHIBIT INDEX</font></b><a name="ExhibitIndex_160253"></a></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="7%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:7.9%;">
  <p style="font-size:8.0pt;font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><!-- SET mrlNoTableShading -->Exhibit&nbsp;No.</p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="89%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:89.38%;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Description</font></b></p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="7%" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:7.9%;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.38%;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="89%" valign="bottom" style="border:none;padding:0pt .7pt 0pt 0pt;width:89.38%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press Release, dated </font>March 5, 2007,
  issued by the Company.</p>
  </td>
  <td width="0%" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>


 <p style="margin:24.0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='4',FILE='C:\fc\61152911874_D11089_1803610\7113-1-ja.htm',USER='jmsproofassembler',CD='Mar  2 15:29 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a07-7113_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>

<head>






</head>

<body lang="EN-US">

<div>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="right" style="margin:0pt 0pt 12.0pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit
99.1</font></b></p>

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;font-family:Times New Roman;">
 <tr style="page-break-inside:avoid;">
  <td width="336" rowspan="9" valign="top" style="padding:0pt .7pt 0pt 0pt;width:252.35pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><!-- SET mrlNoTableShading --><img width="192" height="145" src="g71131mai001.jpg"></p>
  </td>
  <td width="336" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:252.35pt;">
  <p style="margin:0pt 0pt .0001pt;"><b><i><font size="5" face="Times New Roman" style="font-size:18.0pt;font-style:italic;font-weight:bold;">NEWS RELEASE</font></i></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="336" colspan="2" valign="top" style="padding:0pt .7pt 0pt 0pt;width:252.35pt;">
  <p style="margin:0pt 0pt .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">&nbsp;</font></i></b></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contacts:</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International, Inc.</font></u></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mike DePasquale, CEO</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">732-359-1111</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">DRG&amp;E</font></u></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gus Okwu, Managing Director</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="70" valign="top" style="padding:0pt .7pt 0pt 0pt;width:52.65pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="266" valign="top" style="padding:0pt .7pt 0pt 0pt;width:199.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">203-752-0446</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key&#174; Reports Fourth Quarter and Year-end 2006
Results</font></b></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall,
NJ - March 5, 2007</font></b> &#151;
BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless
public safety and finger-based biometric identification solutions, today
announced its financial results for the fourth quarter and fiscal year ended December
31, 2006.</p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total revenue for the three months ended December 31, 2006 increased
19.1% to $4.0 million from $3.4 million reported in the restated financial
statements for the corresponding period in 2005.&#160; The increase in revenues in the fourth quarter
of 2006, compared to the corresponding period in 2005, was driven by an
increase in license fees and other revenue.&#160;
Gross profit for the fourth quarter of 2006 increased 16.3% to $3.0
million from $2.6 million reported for the corresponding period in 2005.&#160; BIO-key&#146;s gross margin for the fourth quarter
of 2006 was 74.1% compared to 75.9% for the corresponding period in 2005.&#160; The reduction in gross margin in the fourth
quarter of 2006 was primarily due to higher cost of services. Gross margin for
the twelve months ended December&nbsp;31, 2006 improved to 77.6% compared to
73% for the previous year. Operating expenses for the fourth quarter of 2006
decreased 4.2% to $4.1 million from $4.3 million reported for the fourth
quarter of 2005.&#160; BIO-key&#146;s operating
loss improved in the fourth quarter of 2006 to $1.2 million compared to an
operating loss of $1.8 million in the corresponding period in 2005.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net income was $21 thousand for the fourth quarter ended December 31,
2006 compared to a net loss of $2.3 million for the corresponding period in
2005.&#160; The fourth quarter 2006 net loss
per fully diluted share was $(0.01) compared to a net loss per fully diluted
share of $(0.05) for the corresponding period in 2005. Earnings per share in
the fourth quarter of 2006 was negatively impacted by charges relating to the
Company&#146;s preferred stock, which included the accretion of accumulated
dividends and the amortization of discounts and stock issuance costs.&#160; These </font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\61175622489_P83101_1804189\7113-1-ma.htm',USER='jmsproofassembler',CD='Mar  2 17:56 2007' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">charges reduced BIO-key&#146;s net income available to common stockholders,
which is used in the calculation of earnings per share.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The increase in 2006 fourth quarter revenue was driven primarily by an
increase in license fees and other revenue, strong maintenance revenue and an
expansion in the range of services - specifically, deployments of additional
BIO-key software - being provided to existing customers.&#160; Gross profit during the fourth quarter of
2006 increased from the corresponding period in 2005 as the Company continued
to generate a larger portion of license related revenues.&#160; As a result, license fees and other revenue
grew to 36.4% of total revenues in the fourth quarter of 2006 compared to 24.5%
in the corresponding period in 2005. Operating expenses declined during the
fourth quarter primarily due to management&#146;s continued focus on cost reduction
programs initiated during 2005.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#147;We believe 2006 was a telling
year for BIO-key as we delivered consistency in our results led by sequential
and year-over-year revenue growth supplemented by ongoing cost control,&#148; said
Michael DePasquale, BIO-key&#146;s Chief Executive Officer.&#160; &#147;We continued to add new business bookings
during the fourth quarter highlighted by Montgomery County&#146;s commitment -
through our channel partner Northup Grumman - to our MobileCop&#153; software and
Erie County&#146;s commitment to FireRMS&#174;.&#160;
The full year&#146;s results included five new customer commitments in excess
of $200,000 with two - Washington/Chisago County (Minnesota) and Onandaga
County (New York) - in excess of $500,000 and one biometric commitment, the
Association of American Medical Colleges, in excess of $350,000. Additionally,
we continued to deepen our customer relationships through existing customers&#146; interest
in expanding their service to new synergistic offerings, as shown by the police
departments of Baltimore, Washington D.C., North Las Vegas and the Chisago
County Sheriff&#146;s Office.&#160; Each of these
agencies either extended or expanded their commitments to include MobileCop or
PocketCop applications.&#148;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total revenue for the twelve months ended December 31, 2006 increased
6.8% to $15.2 million from $14.2 million reported for the corresponding period
in 2005.&#160; It should be noted that several
one-time revenue adjustments related to a Pennsylvania State Police MobileCop
contract were reflected in the second and third quarters of 2006.&#160; Consequently, revenues in those quarters </font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\61175622489_P83101_1804189\7113-1-ma.htm',USER='jmsproofassembler',CD='Mar  2 17:56 2007' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">were positively impacted by $0.5 million in the second quarter and by
$0.8 million in the third quarter.&#160;
Adjusting for those items results in sequential revenue growth for each
quarter throughout the 2006 fiscal year.&#160;
Gross profit for the twelve months ended December 31, 2006 increased
13.6% to $11.8 million from $10.4 million reported for the corresponding period
in 2005.&#160; BIO-key&#146;s gross margin for the
fiscal year ended December 31, 2006 was 77.6% compared to 73% for the 2005
fiscal year.&#160; Operating expenses for the
twelve months ended December 31, 2006 decreased 9.9% to $16.8 million from
$18.7 million reported for the corresponding period in 2005.&#160; BIO-key&#146;s operating loss improved in the 2006
fiscal year to $5&nbsp;million compared to an operating loss of $8.3 million in
the previous year.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net loss was $11.1 million for the twelve months ended December 31, 2006
compared to a net loss of $3.7 million for the corresponding period in
2005.&#160; However, the $11.1 million net
loss amount includes $7.8 million relating to the early extinguishment of debt.&#160; The net loss per fully diluted share for
twelve months ended December 31, 2006 was $(0.24) compared to a net loss per
fully diluted share of $(0.12) for the 2005 fiscal year.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liquidity and Capital Resources</font></u></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consolidated cash and cash equivalents at December 31, 2006 was $0.6
million.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As previously announced, BIO-key completed several initiatives during the
2006 fiscal year highlighted by a restructuring of the balance sheet and an
improvement in the Company&#146;s liquidity.&#160;
These initiatives included the exchange of all of the Company&#146;s
subordinated notes for preferred equity.&#160;
BIO-key also converted a portion of its senior debt to common equity and
deferred several payments until final maturity of the senior debt.&#160; As a result, the Company&#146;s debt obligations
decreased from approximately $11 million to $4.8 million as of year-end
December 31, 2006.&#160; Another initiative
completed during the year was a common equity raise that netted the Company
$1.5 million.</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DePasquale concluded, &#147;We believe that we have stabilized our customer
base over the last twelve to eighteen months by offering a wider range of
compelling software and applications well suited for the first responder
community.&#160; In addition, we have also
succeeded in implementing a focused and disciplined cost control policy that
has improved our operating results.&#160;
However, we remain focused on identifying new products that effectively
strengthen our </font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\61175622489_P83101_1804189\7113-1-ma.htm',USER='jmsproofassembler',CD='Mar  2 17:56 2007' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ties with our customers, and enhancing the value of our currency.&#160; We made great strides during the year towards
achieving our goal of profitability in the future.&#160; As mentioned previously, we take great pride
in the fact that our existing investors confirmed their belief in the long-term
strategy we have taken towards enhancing shareholder value by recommitting in
the restructuring that was completed earlier in the year.&#160; Consequently, we will continue to evaluate
opportunities that will enable us to achieve our goals economically and
accretively.&#148;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conference Call Details </font></u></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key has scheduled a call for Monday, March 5</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&#160;at
9:00 a.m. Eastern Time to discuss fourth quarter and 2006 fiscal year financial
results.&#160; Dialing 303-262-2158 and asking
for the BIO-key call at least 10 minutes prior to the start time can access the
conference call live.&#160; The conference
call will also be broadcast live over the Internet by logging onto
www.bio-key.com.&#160; A telephonic replay of
the conference call will be available through March 14<font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>, 2007 and may be accessed by dialing
303-590-3000 and using the pass code 11085139#.&#160;
Additionally, an archive of the webcast will be available shortly after
completion of the call on the Company&#146;s website (www.bio-key.com) for a period
of three months.</p>

<p style="margin:0pt 0pt 12.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About
BIO-key</font></b></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International, Inc., headquartered in Wall, New Jersey, develops
and delivers advanced identification solutions and information services to law
enforcement departments, public safety agencies, and government and private
sector customers.&#160; BIO-key&#146;s mobile
wireless technology provides first responders with critical, reliable,
real-time data and images from local, state and national databases.&#160; BIO-key&#146;s high performance, scalable,
cost-effective and easy-to-deploy biometric finger identification technology
accurately identifies and authenticates users of wireless and enterprise data
to improve security, convenience and privacy and to reduce identity theft.&#160; Over 2,500 police, fire and emergency
services departments in North America use BIO-key solutions, making BIO-key the
leading supplier of mobile and wireless solutions for public safety
worldwide.&#160; (http://www.bio-key.com)</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This news release contains forward-looking statements that are subject
to certain risks and uncertainties that may cause actual results to differ
materially from those projected on the basis of these statements.&nbsp; The
words &#147;estimate,&#148; &#147;project,&#148; &#147;intends,&#148; &#147;expects,&#148; &#147;believes&#148; and similar
expressions are intended to identify forward-looking statements.&nbsp; Such
forward-looking statements are made based on management&#146;s beliefs, as well as
assumptions made by, and information currently available to, management
pursuant to the &#147;safe-harbor&#148; provisions of the Private Securities Litigation
Reform Act of 1995.&nbsp; For a more </font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\61175622489_P83101_1804189\7113-1-ma.htm',USER='jmsproofassembler',CD='Mar  2 17:56 2007' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0pt 0pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">complete description of these and other risk factors that may affect
the future performance of BIO-key International, see &#147;Risk Factors&#148; in the
Company&#146;s Annual Report on Form 10-KSB and its other filings with the
Securities and Exchange Commission.&nbsp; Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date made.&nbsp; The Company also undertakes no obligation to disclose any
revision to these forward-looking statements to reflect events or circumstances
after the date made or to reflect the occurrence of unanticipated events.</font></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\61175622489_P83101_1804189\7113-1-ma.htm',USER='jmsproofassembler',CD='Mar  2 17:56 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g71131mai001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g71131mai001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`"1`,`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V7-&:**`#
M-&:*0G`R:`%S1FN1U_XBZ1H[-!;'[?<KQLB/R*?=O\,UY[J_CS7]7+*;O[)"
M?^65M\O'NW4UA.O".FYWT,OK5M;67F>PW^NZ5I8S?:A;P'^Z[C=^76N=N_BC
MX>MR1";FZ(_YYQ8'YG%>.L=S%V))/5B<FM#3]"U;5C_H&GSSC^^$POYGBN9X
MF<G[J/2CE=&FKU)?H=[-\78?^6&C2GWDF`_D#5?_`(6[/_T!H_\`O^?\*S;/
MX6Z]<`&XEM;4'LSES^G^-:T/PAX_?ZR?^V<'^)IIXADN.6PT>OWB1_%YL_O=
M%X_V)_\`$5HVOQ8T>0@7-G=P>X`<?H:@'PBL<<ZM<D_]<UJO-\(5Q^XUIL^D
MD`_H:I?6$9/^S9=U]YUNG^-/#NI$+!J<*N?X)3Y9_6MM75E#*00>A!ZUY%>?
M"K7(03;SVET/3<4/Z\?K6:@\8>$'W*EY:Q@\Y'F1'^8JU6G'XXF;P-"I_!J+
MT?\`7Z'N&:,UYWH/Q4@G*PZW`(&/'VB')0_4=1^M=_;7,-W`L]O*DT3C*NC9
M!_&MX5(S^%G!6P]2B[31+FC-%%68!FC-%%`!FC-%%`!FBB@4`%%%9NNZY9^'
M],>]O&X'"(/O2-V`I-I*['&+D[+<DU;6+'1;%KR_G$4:].Y8^@'<UY'XG\>:
MCK[/;VY:SL3QY2GYG'^T?Z#BLG7M?OO$.H-=WC\#B.('Y8U]!_C6<B/+(L<:
M,[N<*JC))]`*\ZK7<W:.Q]+A,OA17/4UE^"&\`>@KHO#O@G5O$.)406UH?\`
MEXE'#?[H[_RKL/"7PXBMECO]<199S\R6IY6/_>]3[=*]`50H`4``#``[5=+#
M7UF8XK-%%\M'[_\`(YC1?A_H>CA9&@^VW`_Y:W'(S[+T%=.JA5"J``.@`QBE
MHKMC%15DCPZE2=1WF[A1115&845%<7,%I"TUS-'#&O5Y&"@?B:Y74/B;X>LV
M*0/->,/^>*?+^9Q4RG&.[-:=&I4^!7.OI"`001D'L:\Z;XMI(V+;0YI/K,,_
MH#4T7Q412/M>@WD2]V4Y_F!6?MZ?<W>`Q"^S^1M:WX"T/60S_9_LEP?^6UN-
MO/N.AKBVL/%'PZN3<VS?:].)^?;DQD?[2]5/O7;Z5X\\/:NXCBO1!*>!'<#8
M?SZ?K70L%=2"`RL,$'D$4G3A/WHO7R+CB*U']W55UV?Z&3X<\36'B2R\^T;;
M(G^MA8_-&?ZCWK8K@-?\'W6C7G_"0>%<Q319:6T7[KCOM'I_L_E73^&O$-MX
MCTM;N'Y)%.V:(GF-O3Z>E5"3ORRW,JU*-O:4OA_%>IL4445J<H4444`%`HH%
M`$<\\5M!)/,X2.-2SL>@`ZFO#/%?B2;Q+J[7!)6VCRMO&?X5]3[FNU^*6O&W
MM(M%@?#W`\R?'9`>!^)_E7EU<&)J7?(CZ'*\,E'VTMWL+7K?@+P6NDP)JFHQ
M`W\JYC1A_J%/_LQ[^E<S\-O#:ZGJ3:I=1[K:S8>6".'DZ_IU^N*]2NM5TVPX
MO-0M;<^DLRK_`#-5AJ7VV99GBW?V,/G_`)%K%+5"UU[1[Z3R[35;*X<_PQ7"
ML?R!J_7:>&%%0_;+4?\`+S%_WV*?'-%*"8I$<#KM8'%`#ZYCQ?XSMO#4(AC4
M3WT@RD.>%']YO;V[UTU>2:WX2N)?%<\^KZQ8P6DTI=KB6Y57"9X4*3G(''I6
M55S2]U'7A(493O6=DOQ,^ULO$GC_`%`R2S-)$C?-+)Q%%[`>OL*[[1_AOH6G
M*K741OYQU:;[N?9>GYYK=T4Z0EA':Z//;26\*X402*^/<X[UHU,**6LM6:5\
M=.?NT_=CV1#!:6UJ@2WMXH5'01H%'Z5*0&&"`1Z&EHK>QPWN9.I>%]$U9"MY
MIL#D_P`:KM8?B.:QETW5_"/[W39IM4TI>7LY3F:(>L;=\>E=9++%!$TLTB1Q
MJ,LSL`!^)HCDCFC62)UD1AE64Y!'J#4.">JW-8UII<KU79D-A?6VI6<=Y:2B
M2&495A_(^AKDM;LF\):XOB;3T(LIF":C`@XP3_K`/K_GFML6PT;6_-@&VSU%
M\2H.D<W9AZ;L8/OCUK6N+>*ZMI+>=`\4JE74]P>M)KF7FAQFJ<KK6+_(=%(D
MT:R1L&1U#*PZ$'H:?7.^$6ELX;O0KARTFF2[(V/5H6Y0_ED?A71547=7,YQY
M9-!1115$!0**!0!\]:UJ4NKZQ=7TI)\V1B@/\*YX'Y52`+,%498G``[FO3]<
M^%D=U=O<Z5>K;B1BS0S*2JDG/!'0>U6/#'PUBTF^2^U*Y2ZFB.8HT4A%/8G/
M4UYOU>HY:GTZS'#PI7B_D8'C_3/$'ASX>V*:/>_9;2V7.H>6VR1W8C!!],DC
M'TKS;P)X3;QSXC>QGO6@1(FFEEQO8@$#`SWR:]P^+8_XMMJ?_;/_`-&+7EOP
M4O;73O$]_>7MQ';V\5@Q>21@JK\Z=Z]%))61\U*3E)R>[)_'7PC/A31FUG3-
M1DN8H&'G)(H5U!.`P(]\5N?"/QA>>((KSPKJ]S+/FV8P3ECY@3[K+NZ\9R#4
M_P`3_B5H-[X7N-%TB\%[<7>U7>-3LC4$$\GJ>,<5G?`[PM>IJ4_B.YB>*V$)
MAM]PQYI)&2/8`=?>F2<)X]\-P^$_%4^DVUS+/$B(ZO+C=\PS@XKV+X2>%+30
M_#L>O_;)GEU&V#RJ[`1Q@$GI_4UYM\:?^2C7/_7"+_T&NUU75I-)_9]L3"Q6
M2ZMH[<$'D!B=W_CH-`'+>//BEJGB+47TS0)I;;3P_EH821)<G.,Y'.#V`_&M
M/1?@5?7]HMUKFK&TGE&XPQQ^8R_[S$]?I7/_``:TJ/4_'T,LJ!DLHFN,'^\,
M!?U;/X5]'T`?.?BSX<Z]X`VZO87[S6J,!]IM\QO$>VX`]/?-=_\`"OXE2^)"
M=%UEU.HQINBFQCSU'7(_O#]17H6J:?#JNE76GW"AHKF)HV!]QBOE/2;V?P[X
MGMKM&VRV-R,^^&P1^(R*`/K>BFHXD177HP!%.H`^>_C);:_8^(%_M+5FNK*[
M+R6L*DA8E!^Z5Z9&1SWKU?X6DGX;Z/DD_NV'/^^U>??M`?\`(1T7_KC+_-:Z
M3PEXQT;PA\,M`DU>:2/[0L@C$<9<G#G/3ZB@#T*]MOM=JT.=I)#*WH0<@_F*
ML5QND?%;PKK6J0:;9W-P;BX;9&'@8`GTS6YX@\3Z/X7LA=ZM>+`C'"+U>0^B
MJ.30%QEQ%]F\66ETO`O+=[>3W*_.OZ;JV:\PF^-'A*[O+;?%J,:P3;Q)Y*D=
M".1NSCFNAU'XH>$],L[2ZDU$S17@8Q&",OTZY]#ST/-)*Q4G=(ZZBN(L?B]X
M0U"_@LH;JX$MQ((TWV[`;B<#GZU>\1?$;PYX6U(:=J=Q,MQL#E8X2V`>G-,D
MZF@5RND_$?PYK=M<3V-Q,_V8J'1HBK'.<8SQV/TQ6[INJV^J([0!U9,;D<#(
MST/!((X/(/8T`7:***`.-^+7_)-M4_[9_P#HQ:\C^$FA6/B36=3TO449[::Q
M)8*VT@B1""#]:]5^,%Y;0?#V^@EN(TEG*"*-F`9R'4G`[\5YS\"'5?&=TI(!
M:Q;`]?G6@#5\:_!>RTS0[C5-"NKAGM4,DEO.0VY!UVD`<@<U4^$GQ"U"'6;;
MPYJ5P]Q9W'[NW:0Y:%L<`'^Z>F.W%>L^,]5M=&\(ZE=W;JJFW>-%)^^[`@*/
M7)-?.WPXL)M0\?:1'"I/EW`E<@?=5>2?TH`U_C1_R46Y_P"N$7_H-='XLA>3
MX!:"ZCB)HBWT(8?S(KG/C1_R46Y_ZX1?^@UZCHNAKXD^"UGI+$*UQ8`1L>BN
M#E3^8%`'G_P&F1/%][$Q&Z2R.W\'6O?:^5_"^K7/@?QK!=W<+QM:2F*YB(^;
M:>&']?PKZ>T[4K+5[&.]L+F.XMY1E7C.1_\`6/M0!:)`&3T%?(.J,+K7;QXN
M1+=.5QWRQQ7T7\2?&MGX7\/W$"3HVIW49C@A4Y9<C&\^@'\Z\:^%WA67Q+XM
M@D>,FRL6$]PY'!P<JOU)_0&@#UO6/BIH/A2_&BWT-[+<VT*"0PQJ5!*@XY([
M5G_\+X\,_P#/CJ7_`'[3_P"*KJ-9^'OA?7]1?4=2TP37,@`>02NN[`P,@$=J
MH_\`"H_!'_0'_P#)B3_XJ@#S?XT:K;:W%X<U.SW>1=6LDB;Q@@$KU%9=QXG.
ML^"]!\#Z7;QR7#MMFEE4#:YD.U5)Z=02?P]:V?CC8VNF2Z!8V<0AMX+:1(XQ
MT4`K7+:IX,N++P5I/BNS9W@N%(N1WA<.0I'L<#Z'ZT`>[^#?`FE>$=-BCC@B
MGO@,S7;(-[-WVD]![5X7K^H7GCWXC"%Y6V7%V+:W7/$<>[`Q^'/UKUWX6>/%
M\5:3_9VH2C^U+1,.3UF3H'^O8_GWKQ)X9/#OCMX+F62U:UO&1I4^]&"<;Q^!
MR*`/2OB4G@/0/"KZ!9V=J=40*(?(4&2(@C+._7D9X/7/2L?X7^";O7M&U=-2
MM-FG7=OMM9)4Y$W9TSSQW(Z]*[+PC\(=#TTIJ6I7`UN=SYD;L/W//(;&3N/?
M)-=;I_B[0-0UR70;"^CEO+9-S1Q@[0!P0&Z'''`H`\&^'%W'X:^(\-KJUO'S
M(UJYE0$PR9P&&>AW`#/H:[;XXW$-S)I&B6UM%)J-S+NW[!Y@7.U5SUP23^58
M'QM\.G2_$T.N6ZE(=0'SE>-LJ]?S&#^!JS\.?MOCSXB_\)#JH#KIMNAX'R[P
M-J?KN;ZT`>EV?@BTT_PO:Z39K%#+"@\R39_KF*D/N(YYR>>W%:FB:.^F*[2N
MA9@$1(\[8T#,V,GDG+'DUD:G\2-!TV[:V#373H<.T"`J#Z9)&?PK4T'Q1I?B
M-'-A,2\8R\4B[74>N/3WJ%4BW9,VE0JQCSRB[&Q1115F)R/COX>V/CB*!IKF
M2UNK8$12H-PP>H*]Z\U?X(>*M.N1/I>K6C.A^21)'B<?IQ^=>\5G>()Y;;PY
MJ5Q!(8Y8K25T=>JL%)!H`\>/P?\`&VLRI_;>O0LBG@RW$DY7Z`C^M>B>%?AY
MI_A'2KF'3IW.HW,11K]U&Y21QM'8`\X]JY34_%/B.RTWP9?64\MT\MB]S>P9
M_P"/E552V??!8BM_0M2G\7:EXDAM=9N8K-OLK6<T!&Z%6CW';D'&3US0!QM]
M\#_$6I7;W5[XDM[F=_O2RAV8_B:[?X?>#-:\(QSP:CKOVZU*!8+90VR(YR2,
M]/H*I^!+?5;R^U2ZO?$>I72:;J$UHD$K+LD51P6XSGG/'I7/^%-7O]56SDO-
M;\6-/+<%6\BV#6W#D#Y]O3'7\:`.P\:?#31_&)^TR%K/4`,"YB&=P[!A_%_.
MO.3\&_&FERLNDZQ!Y;=6BN'A)^H`KH/$WB)K3QMK-OJ'B36-,L[6.`P+8Q;T
M!9>=WRG'.,9QG-3:KK'C*'X?:!/YSPZU<WZQC("F93N*!P..0%R*`,/3/@5J
MEU=";7M9B56.7$&Z21O^!-C'UYKUO0=`TWPUIJ:?I=N(85Y/=G/JQ[FN6\->
M+)?$GC.`P3R):2:/YDMH>D4XEVL"/4=/I65;>-;YO'HOI-00Z!<7KZ9';[Q\
MKA1B7'7!?(S0!ZA17G?B+3]7@\:Z380>*M6A@U>2=G1&3$(5=P"?+TYQSFKL
MFJ7VD^.VL)+V>YM+30#<,CD?O)%;&\X'WB!0!SOBWX3^(_%.N37T_B."2'>W
MV>.9&_<H3G:`./\`&M_P3X#U+0=)O=(US58]3TVXC\N.T"G9&#G=UZ9SVK)C
M/B>X\$-XV'B>Y2[\EKM;((OV4("3Y97&3P.N:7Q!XTUBSU[0=3LQ(VG2:6+V
M_LUY'EE@&8>Z[@?PH`R4^"6M:9K!O=$\1QVH1R8'*L)%4]B1UXX]ZZ;Q;\++
M?Q596T\U]Y>LPPK')>"/Y;@@8RRC^8JWX:\3>;%XIU.[OC<6%E>,T#9R%B$:
ML`OMS69\//$VJW6M26.N7R7#:G;#4+-0X/DJ6.Z+CH0,'%`'+P?"/QU#%_9Z
M>(XHK$\;$NI=N/\`=Q7?^!?AUIW@J)YDE-W?S+MDN&7``_NJ.PS^=3^"M2O=
M1N/$*WEP\PMM6EAA#8^1`!A174$X!.,^U`'G'QPU'3X/!R6%RH>[N9E:V7/*
M;?O-],''XUD:);MX,^$*2`^5J&M-OST8*PX_)!_X]6!J&@^*O'WQ$275='O;
M2R\X(?-C*I#`IZ9/&2,_4FM#QSKL>L:UY-J1]BL5\F`+T..I'Y8^@K"O/D@=
MV`H>VK*^RU9S72NW^%$;MXGN)`#L2T8,?JRX'Z'\JXBO9/AMHATOP]]JF3;/
M?'S#D<A/X1_7\:XL/'FFO(]S,:JAAVN^AU]%%%>H?*A5;4;)=1TRZL7<HMS"
M\18#E0P(S^M6:*`.<L_!MM9SZ#*+N1_[#MGMXU*C$H90I+>G2E\,>#;'PG=Z
MG-I\C^5J$HD\D@;8L9X7VYKHJ0C-`'->$+?28/[8&FZBUT;F_DGG5EVF%VZK
MCTXJCI?@/4]&MX[2P\87\5I$Y98!;Q$<MN(R1GDDU'XKTB^T34_^$JT$?O%'
M^FVXZ2K_`'L?S_.M_P`.>)K#Q)9">U?;*H_>P,?FC/\`4>]9QGKRRW.B='W%
M4AJOR?F9&IVN@Z/KFIW>LW$ABUZ*.&2.6(F%0@*XW`<$Y[T^Q\'6SZ'I%DFL
MRW=OI=ZMU;2_*Q*KG;&2.H&>M=1<VT%Y;M!<PI-$XPR.N0:Y&Z^'D<$K3^']
M5NM)D)SY:.6C_+.13DY)Z*XH1I25I.S^]?Y_F6X?`ME9^)-4UVPNI+6XU*V:
M%U1051CC,@]\C./6J3_"KPTWAU=+2V2.Z5%`U%8QY^\'.[/K5232?B1:_+!K
M-O=+V)*@_JM5)=(^)EW\LNH+$IZE)U3_`-!&:AU7_*S986+_`.7D?O\`^`=+
MK=GIMIJ&CZUJVK^2^DHX&X`>>64*3CKGC/%8#>*?"4WBPZZU[=/(]E]B^S_9
MB592V[/KGMBJEM\*]3NYO.U?5TR?O%-TCG\6KLM#\&:+H!$EM;>9<#_EO,=S
M_AV'X4E*K)[614H82G'63D_+1&!;_#Q+K35L8=?U2#0)FW_V6Z*I"DYV;B-P
M7VKHW\+V;:];:H&PEO8M8K;;1L,9(/\`3%;5%;G`<3;?#*PL_#NH:%;:A<1V
M=_=">0!1D(,?NP?3@<U>D^'^APZGI^HZ3;1:5<6,WF;K:(#S5(P4;U!%=110
M!QR>!K^TO[ZYTSQ7>V,=]<M<R0QP1L`S=>6!/I77J"J`,VX@<D]Z7-<'XQ^(
M4-@LFGZ-(LMW]UYQRL7T]6_E43FH*[-J-&=:7+!!\0_&(L8'T;3Y<W4JXG=3
M_JE/;ZG]!7E-.=WDD:21B[N<LS'))]36CH.@WGB'45L[1<`<RRD?+&OJ?\*\
MR<Y59'U-"C3PE+5^K-'P3X9?Q%JZF5#]BMB&G;LWHGX_RKVY%"J%4``#``[5
M1T71[30]-CL;-,)'U8]7;NQ]S5\5Z%&G[./F?.8S$O$5+]%L%%%%;'&%%%%`
M!1110`A&>M>?>)?!-WI]Z==\+,\$ZG=);QG&?4K_`%6O0J,5$X*:LS:C6E1E
M>/\`PYP'A_XFV\I%IKT1M)U.TS!3L)_VAU4UW5O<0W4*S6\J2QL,AT8,#^(K
M!\1^"=*\1`RR)]GN\<7$0Y/^\/XJ\]NO#OBSP;,T]C),T`.?-M"64C_:3_ZU
M8N=2G\2NCM5'#XC^&^679[?(]EHKR;3OBMJL`"7]I!=@=63,;?U%=!:_%;1)
M0/M-M=VY_P!T./T-7&O3?4RGE^(A]F_H=S17+Q_$7PO(,G42GL\+C^E2'X@^
M%@/^0JA^D;_X5?M(=S#ZM6_D?W,Z2BN0G^)_AN$'9+<SD?W(3_7%8M[\7$P1
MI^E,3V:>3`_(?XU+K4UU-(X+$2V@_P`CTFL;6O%>CZ"A^VW:^;V@C^:0_AV_
M&O)]4\>>(=5#(U[]FB;_`)9VPV?KU_6N>8DL68DD\DDY)KGGBE]E'H4<I;UJ
MO[CJ_$GQ!U+7`]M:YL;-N"B-\[C_`&F_H*Y/I6GI/AW5];D"V%E)(O>5AM0?
M\"/%>A^'_AA9616XUB07LPY$*\1*??NU8*%2L[L]"5?#8./*ON6YQ/AGP=J/
MB24.BFWL@?GN''!]E'<_I7L>C:)8Z%8+9V,6Q!RS'EG/J3W-7HXTBC6.-%1%
M&`JC``]A3J[J5&-/U/!Q6,J8AZZ+L%`HH%;'$%%+10`E%+10`E%+10`E%+10
M`E&*6B@#%U3PCH>L$M=Z?$9#_P`M8_D?\Q7*WWPDM'):PU.6+T29`X_,8->B
M45G*E"6Z.FGBJU+X9,\AN/A5KT1/DW%G..WSE3^HJH?AKXG!_P"/6`_2=:]I
MI*R>&ILZEFN(6]G\CQ?_`(5KXH_Y]8/^_P"M3P?"[Q%*<2-:0CU:4G^0KV*B
MCZK3&\UQ#[?<>:6?PB.0;_5N.ZP1?U/^%=-IO@#P[IA#K9?:)!_'<-O_`$Z?
MI72T5I&C".R.6IC*]324OT&(BQJ$10JC@`#`%.Q2T5J<HF**6B@!**6B@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
$@#__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
